Molecular imaging for early response assessment of neo-adjuvant chemotherapy and drugs targeting the PI3K/Akt/mTOR pathway in HER-2 amplified breast cancer
Source
Antwerp, University of Antwerp, 2024,223 p.
¹⁸F-FDG and ¹⁸F-FLT uptake profiles for breast cancer cell lines treated with targeted PI3K/Akt/mTOR therapies
Source
Cancer biotherapy and radiopharmaceuticals - ISSN 1084-9785-38:1 (2023) p. 51-61
Early changes in [¹⁸F]FDG uptake as a readout for PI3K/Akt/mTOR targeted drugs in HER-2-positive cancer xenografts
Source
Molecular Imaging - ISSN 1536-0121-2021 (2021) p.
The predictive value of sentinel node biopsy in early breast cancer after neo-adjuvant chemotherapy : a prospective study
Source
European journal of obstetrics and gynecology and reproductive biology - ISSN 0301-2115-229 (2018) p. 108-111
Neoadjuvant systemic therapy in breast cancer : challenges and uncertainties
Source
European journal of obstetrics and gynecology and reproductive biology - ISSN 0301-2115-210 (2017) p. 144-156